肥胖不孕女性体外受精前减重干预:一项随机对照试验
这项前瞻性多中心随机对照试验在瑞典、丹麦和冰岛9家不孕诊所纳入317例BMI≥30且<35 kg/m2、计划行体外受精(IVF)的女性,比较IVF前强化减重(低热量液体配方饮食880 kcal/天)与直接IVF的活产率。全分析集显示减重+IVF组活产率29.6%(45/152)与单纯IVF组27.5%(42/153)差异无统计学意义(差值2.2%,95%CI:12.9至-8.6,P=0.77);减重组平均体重变化-9.44(6.57)kg,对照组+1.19(1.95)kg(P<0.0001)。
要点
- IVF前强化减重未显著提高肥胖不孕女性的活产率。
- 减重组自然妊娠活产率10.5%(16例)高于对照组2.6%(4例)(P=0.009)。
- 减重组平均体重变化-9.44(6.57)kg,对照组+1.19(1.95)kg(P<0.0001)。
核心结论
- 强化减重方案使肥胖女性体重明显下降,但未实质性影响计划行IVF的肥胖女性的活产率。
研究设计与样本
- 前瞻性多中心随机对照试验,2010年至2016年在北欧国家进行,962例评估资格,317例随机分组,按1:1分配至减重后IVF组或单纯IVF组,每组纳入一个周期。
- 参与中心为瑞典、丹麦和冰岛9家不孕诊所;纳入年龄<38岁、BMI≥30且<35 kg/m2、计划行IVF的女性。
- 减重组(160例)在IVF前接受12周低热量液体配方饮食(LCD)880 kcal/天,随后2-5周体重稳定期;对照组(157例)仅行IVF。
主要发现
- 全分析集(FAS)中,减重+IVF组活产率29.6%(45/152),单纯IVF组27.5%(42/153),差异无统计学意义(差值2.2%,95%CI:12.9至-8.6,P=0.77)。
- 减重+IVF组平均体重变化-9.44(6.57)kg,单纯IVF组+1.19(1.95)kg,组间差异高度显著(P<0.0001)。
- 减重+IVF组自然妊娠活产率10.5%(16例),单纯IVF组2.6%(4例),差异有统计学意义(P=0.009)。
- 两组流产率及IVF刺激所用促性腺激素剂量无差异。
- 两项亚组分析(PCOS女性组间比较;减重组达到BMI≤25 kg/m2或减重至少5个BMI单位者与单纯IVF组比较)均未发现活产率统计学差异。
临床怎么用
- 作者认为,对于肥胖女性(BMI:30-34.9 kg/m2),减重可能不会改善IVF周期的结局,尽管减重组自然受孕数量显著更高。
- 作者认为,采用LCD治疗的强化减重不会对结果产生负面影响。
局限性
- 研究把握度不足以检测减重带来的活产率小幅增加。
- 研究对患者和医生均未设盲。
- 干预组实现自然妊娠的时间更长,因此在IVF时年龄略大于对照组。
- 研究仅纳入BMI低于35 kg/m2的女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does an intensive weight reduction programme prior to IVF increase live birth rates for infertile obese women? SUMMARY ANSWER: An intensive weight reduction programme resulted in a large weight loss but did not substantially affect live birth rates in obese women scheduled for IVF. WHAT IS ALREADY KNOWN: Among obese women, fertility and obstetric outcomes are influenced negatively with increased risk of miscarriage and a higher risk of maternal and neonatal complications. A recent large randomized controlled trial found no effect of lifestyle intervention on live birth in infertile obese women. STUDY DESIGN, SIZE, DURATION: A prospective, multicentre, randomized controlled trial was performed between 2010 and 2016 in the Nordic countries. In total, 962 women were assessed for eligibility and 317 women were randomized. Computerized randomization with concealed allocation was performed in the proportions 1:1 to one of two groups: weight reduction intervention followed by IVF-treatment or IVF-treatment only. One cycle per patient was included. PARTICIPANTS/MATERIALS, SETTING, METHODS: Nine infertility clinics in Sweden, Denmark and Iceland participated. Women under 38 years of age planning IVF, and having a BMI ≥30 and <35 kg/m2 were randomized to two groups: an intervention group (160 patients) with weight reduction before IVF, starting with 12 weeks of a low calorie liquid formula diet (LCD) of 880 kcal/day and thereafter weight stabilization for 2-5 weeks, or a control group (157 patients) with IVF only. MAIN RESULTS AND ROLE OF CHANCE: In the full analysis set (FAS), the live birth rate was 29.6% (45/152) in the weight reduction and IVF group and 27.5% (42/153) in the IVF only group. The difference was not statistically significant (difference 2.2%, 95% CI: 12.9 to -8.6, P = 0.77). The mean weight change was -9.44 (6.57) kg in the weight reduction and IVF group as compared to +1.19 (1.95) kg in the IVF only group, being highly significant (P < 0.0001). Significantly more live births were achieved through spontaneous pregnancies in the weight reduction and IVF group, 10.5% (16) as compared to the IVF only group 2.6% (4) (P = 0.009). Miscarriage rates and gonadotropin dose used for IVF stimulation did not differ between groups. Two subgroup analyses were performed. The first compared women with PCOS in the two randomized groups, and the second compared women in the weight reduction group reaching BMI ≤ 25 kg/m2 or reaching a weight loss of at least five BMI units to the IVF only group. No statistical differences in live birth rates between the groups in either subgroup analysis were found. LIMITATIONS, REASON FOR CAUTION: The study was not powered to detect a small increase in live births due to weight reduction and was not blinded for the patients or physician. Further, the intervention group had a longer time to achieve a spontaneous pregnancy, but were therefore slightly older than the control group at IVF. The study only included women with a BMI lower than 35 kg/m2. WIDER IMPLICATIONS OF THE FINDINGS: The study suggests that weight loss for obese women (BMI: 30-34.9 kg/m2) may not rectify the outcome in IVF cycles, although a significant higher number of spontaneous conceptions occurred in the weight loss group. Also, the study suggests that intensive weight reduction with LCD treatment does not negatively affects the results. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by Sahlgrenska University Hospital (ALFGBG-70 940), Merck AB, Solna, Sweden (an affiliate of Merck KGaA, Darmstadt, Germany), Impolin AB, Hjalmar Svensson Foundation and Jane and Dan Olsson Foundation. Dr Thurin-Kjellberg reports grants from Merck, non-financial support from Impolin AB, during the conduct of the study, and personal fees from Merck outside the submitted work. Dr Friberg reports personal fees from Ferring, Merck, MSD, Finox and personal fees from Studentlitteratur, outside the submitted work. Dr Englund reports personal fees from Ferring, and non-financial support from Merck, outside the submitted work. Dr Bergh reports and has been reimbursed for: writing a newsletter twice a year (Ferring), lectures (Ferring, MSD, Merck), and Nordic working group meetings (Finox). Dr Karlström reports lectures (Ferring, Finox, Merck, MSD) and Nordic working group meetings (Ferring). Ms Kluge, Dr Einarsson, Dr Pinborg, Dr Klajnbard, Dr Stenlöf, Dr Larsson, Dr Loft and Dr Wistrand have nothing to disclose. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov number, NCT01566929. TRIAL REGISTRATION DATE: 23-03-2012. DATE OF FIRST PATIENT'S ENROLMENT: 05-10-2010.
引用
- Einarsson S, Bergh C, Friberg B, et al. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial. Hum Reprod. 2017. PMID: 28854592. doi:10.1093/humrep/dex235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。